Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Walter Bock

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Biochemical Pharmacology|October 11, 2015
The UDP-glycosyltransferase (UGT) superfamily expressed in humans, insects and plants: Animal-plant arms-race and co-evolutionKarl Walter Bock
Biochemical Pharmacology|December 24, 2011
Ah receptor- and Nrf2-gene battery members: modulators of quinone-mediated oxidative and endoplasmic reticulum stressKarl Walter Bock
Biochemical Pharmacology|June 23, 2019
Aryl hydrocarbon receptor (AHR): From selected human target genes and crosstalk with transcription factors to multiple AHR functionsKarl Walter Bock
Biochemical Pharmacology|May 5, 2015
Roles of human UDP-glucuronosyltransferases in clearance and homeostasis of endogenous substrates, and functional implicationsKarl Walter Bock
Biochemical Pharmacology|September 2, 2003
Vertebrate UDP-glucuronosyltransferases: functional and evolutionary aspectsKarl Walter Bock
Biochemical Pharmacology|November 23, 2020
Aryl hydrocarbon receptor (AHR), integrating energy metabolism and microbial or obesity-mediated inflammationKarl Walter Bock
Biochemical Pharmacology|June 15, 2020
Aryl hydrocarbon receptor (AHR) functions: Balancing opposing processes including inflammatory reactionsKarl Walter Bock
Biological Chemistry|November 3, 2016
Human and rodent aryl hydrocarbon receptor (AHR): from mediator of dioxin toxicity to physiologic AHR functions and therapeutic optionsKarl Walter Bock
Archives of Toxicology|September 24, 2021
Aryl hydrocarbon receptor (AHR) functions in infectious and sterile inflammation and NAD<sup>+</sup>-dependent metabolic adaptationKarl Walter Bock
Biochemical Pharmacology|December 4, 2018
Human AHR functions in vascular tissue: Pro- and anti-inflammatory responses of AHR agonists in atherosclerosisKarl Walter Bock
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Biochemical Pharmacology|October 11, 2015
The UDP-glycosyltransferase (UGT) superfamily expressed in humans, insects and plants: Animal-plant arms-race and co-evolutionKarl Walter Bock
Biochemical Pharmacology|December 24, 2011
Ah receptor- and Nrf2-gene battery members: modulators of quinone-mediated oxidative and endoplasmic reticulum stressKarl Walter Bock
Biochemical Pharmacology|June 23, 2019
Aryl hydrocarbon receptor (AHR): From selected human target genes and crosstalk with transcription factors to multiple AHR functionsKarl Walter Bock
Biochemical Pharmacology|May 5, 2015
Roles of human UDP-glucuronosyltransferases in clearance and homeostasis of endogenous substrates, and functional implicationsKarl Walter Bock
Biochemical Pharmacology|September 2, 2003
Vertebrate UDP-glucuronosyltransferases: functional and evolutionary aspectsKarl Walter Bock
Biochemical Pharmacology|November 23, 2020
Aryl hydrocarbon receptor (AHR), integrating energy metabolism and microbial or obesity-mediated inflammationKarl Walter Bock
Biochemical Pharmacology|June 15, 2020
Aryl hydrocarbon receptor (AHR) functions: Balancing opposing processes including inflammatory reactionsKarl Walter Bock
Biological Chemistry|November 3, 2016
Human and rodent aryl hydrocarbon receptor (AHR): from mediator of dioxin toxicity to physiologic AHR functions and therapeutic optionsKarl Walter Bock
Archives of Toxicology|September 24, 2021
Aryl hydrocarbon receptor (AHR) functions in infectious and sterile inflammation and NAD<sup>+</sup>-dependent metabolic adaptationKarl Walter Bock
Biochemical Pharmacology|December 4, 2018
Human AHR functions in vascular tissue: Pro- and anti-inflammatory responses of AHR agonists in atherosclerosisKarl Walter Bock
Pageof 5